What is Miebo?
Miebo (perfluorohexyloctane ophthalmic solution) is a prescription eye drop used to treat the signs and symptoms of dry eye disease [1]. It is a prescription medication [2].
How Does Miebo Work?
Miebo is a non-steroidal, water-free liquid that works by reducing evaporation from the eye's surface [1]. It helps to restore the lipid layer of the tear film, which is often deficient in individuals with dry eye disease [1][2].
What Does Miebo Cost?
The cost of Miebo can vary significantly. Without insurance, a prescription for Miebo may cost around $475 to $500 [3].
Does Medicare Cover Miebo?
Information regarding Medicare coverage for Miebo is not readily available in the provided text. It is advisable to check with your specific Medicare plan or a pharmacist for coverage details [3].
Are There Savings Programs for Miebo?
Yes, there may be savings programs available for Miebo. The manufacturer offers a savings card that can reduce the out-of-pocket cost for eligible patients [3].
What Are the Potential Side Effects of Miebo?
Common side effects of Miebo can include blurred vision and eye irritation [1].
When Did Miebo Become Available?
Miebo was approved by the U.S. Food and Drug Administration (FDA) in May 2023 [1].
What Are Other Treatment Options for Dry Eye Disease?
Other treatments for dry eye disease may include artificial tears, prescription eye drops like cyclosporine or lifitegrast, punctal plugs, and lifestyle modifications [4].
How Does Miebo Compare to Other Dry Eye Treatments?
Miebo is distinguished by its water-free formulation designed to address lipid layer deficiency and reduce tear evaporation, a common underlying cause of dry eye [1][2]. Many other treatments focus on increasing tear production or reducing inflammation.
---
Sources:
[1] https://www.miebo.com/
[2] https://www.drugpatentwatch.com/p/drugs/17831/miebo
[3] https://www.miebo.com/savings-and-support
[4] https://www.nei.nih.gov/learn-about-eyes/eye-health-literacy/dry-eye-overview